Upgrade to SI Premium - Free Trial

Syndax Pharmaceuticals (SNDX) PT Raised to $34 at Goldman Sachs

April 1, 2026 6:18 AM
Goldman Sachs analyst Corinne Johnson ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst PT Change